Health
Could SARS-CoV-2 antibody tests before first vaccine dose help increase coverage and protection? – News-Medical.Net
A new study by scientists in the UK raises the very useful hypothesis that natural infection may help spread the vaccine thinner without loss of efficacy.
The end of the ongoing coronavirus disease 2019 (COVID-19) pandemic may be in sight, with several countries having rolled out vaccination programs against the causative pathogen: severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). These campaigns aim to induce population immunity rapidly.
A new study by scientists in the UK raises the very useful hypothesis that natural infection may help spread the vaccine thinner without loss of efficacy.
However, as new variants continue to emerge,…
-
General23 hours agoCoalition abandons ‘end’ to work from home, walks back 41,000 job cuts
-
Noosa News13 hours agoBanana farmers still salvaging fruit four weeks after ex-Tropical Cyclone Alfred
-
Noosa News13 hours agoQueen Street Mall to get a 3D digital billboard; Dutton dumps controversial plans to end flexible work; Measles alert for tourist hotspots
-
Business16 hours ago5 things to watch on the ASX 200 on Monday 7 April 2025